Merck: Navigating Patent Cliff and Growth Prospects
Merck faces the challenge of expiring patents while pushing a robust pipeline and disciplined capital moves. This gui...
Survey what’s included in dividend ETF fees, from management costs to trading and other ancillary charges that affect net returns.
11,381 articlesMerck faces the challenge of expiring patents while pushing a robust pipeline and disciplined capital moves. This gui...
Two Harbors postpones its special meeting to vote on its sale to CrossCountry Mortgage, while pushing UWM to submit a...
Investors are weighing a bold 2028 target for McDonald’s as loyalty growth and margin leverage could lift the stock, ...
SpaceX is making waves in public markets with headlines about rapid gains and sky-high valuations. This article cuts ...
Micron Technology rides the AI memory wave, but a blowout earnings report invites questions. This guide breaks down t...
JPMorgan Chase stands out for its scale, diversified earnings, and capital strength, reinforcing its role as a steady...
As 2026 unfolds, investors face a clear choice between Lilly's growth engine in big markets and Teva's value-forward ...
A new Fed chair promises reform, but progress stalls. This article explains the investing implications when it's been...
A blockbuster TSMC update is reshaping the AI chip market. Here are three stocks I’m buying after Taiwan’s announceme...
As defense budgets stay elevated and geopolitical tensions linger, investors are targeting the best aerospace and def...
Stepan (SCL) investors are focused on 2025 earnings drivers, margins, and cash flow. This guide breaks down the key c...
Wix has endured a brutal stock down year, dropping roughly 70% as growth worries and macro headwinds hit software nam...